Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0175 | 1 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2712 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0102 | 0.0375 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0959 | 0.3537 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0959 | 0.0866 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0102 | 0.0375 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0175 | 1 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0959 | 0.3537 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1504 | 0.1416 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0102 | 0.0375 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0959 | 0.3537 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0175 | 1 | 0.5 |
Schistosoma mansoni | lamin | 0.0033 | 0.0959 | 0.0866 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0959 | 0.3537 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0959 | 0.0866 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0175 | 1 | 0.5 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0959 | 0.0866 |
Onchocerca volvulus | 0.0033 | 0.0959 | 0.5 | |
Giardia lamblia | Rrm3p helicase | 0.0175 | 1 | 0.5 |
Schistosoma mansoni | lamin | 0.0033 | 0.0959 | 0.0866 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2712 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0175 | 1 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0959 | 0.0866 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2712 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0959 | 0.3537 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0959 | 0.0866 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0921 | 0.3397 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1504 | 0.5545 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 1 | 1 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0175 | 1 | 0.5 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0175 | 1 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0102 | 0.0375 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0175 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1504 | 0.5545 |
Echinococcus granulosus | lamin | 0.0033 | 0.0959 | 0.0866 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0175 | 1 | 0.5 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0175 | 1 | 1 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0959 | 0.0866 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0175 | 1 | 0.5 |
Onchocerca volvulus | 0.0033 | 0.0959 | 0.5 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2712 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.